Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 524

1.

Are dopamine receptor agonists neuroprotective in Parkinson's disease?

Le WD, Jankovic J.

Drugs Aging. 2001;18(6):389-96. Review.

PMID:
11419913
[PubMed - indexed for MEDLINE]
2.

Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease.

Radad K, Gille G, Rausch WD.

Pharmacol Rep. 2005 Nov-Dec;57(6):701-12. Review.

PMID:
16382188
[PubMed - indexed for MEDLINE]
Free Article
3.

Do dopamine agonists provide neuroprotection?

Yamamoto M.

Neurology. 1998 Aug;51(2 Suppl 2):S10-2. Review.

PMID:
9711974
[PubMed - indexed for MEDLINE]
4.

Dopamine agonists.

Factor SA.

Med Clin North Am. 1999 Mar;83(2):415-43, vi-vii. Review.

PMID:
10093586
[PubMed - indexed for MEDLINE]
5.

Do dopamine agonists or levodopa modify Parkinson's disease progression?

Marek K, Jennings D, Seibyl J.

Eur J Neurol. 2002 Nov;9 Suppl 3:15-22. Review.

PMID:
12464117
[PubMed - indexed for MEDLINE]
6.

Pre-clinical studies of pramipexole: clinical relevance.

Hubble JP.

Eur J Neurol. 2000 May;7 Suppl 1:15-20. Review.

PMID:
11054154
[PubMed - indexed for MEDLINE]
7.

Clinical pharmacology of dopamine agonists in Parkinson's disease.

Lange KW.

Drugs Aging. 1998 Nov;13(5):381-9. Review.

PMID:
9829165
[PubMed - indexed for MEDLINE]
8.

Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.

Bennett JP Jr, Piercey MF.

J Neurol Sci. 1999 Feb 1;163(1):25-31. Review.

PMID:
10223406
[PubMed - indexed for MEDLINE]
9.

Ropinirole and pramipexole, the new agonists.

Hobson DE, Pourcher E, Martin WR.

Can J Neurol Sci. 1999 Aug;26 Suppl 2:S27-33. Review.

PMID:
10451757
[PubMed - indexed for MEDLINE]
10.

Neuroprotection in idiopathic Parkinson's disease.

Reichmann H.

J Neurol. 2002 Oct;249 Suppl 3:III/21-3. Review.

PMID:
12522567
[PubMed - indexed for MEDLINE]
11.

Neuroprotection and dopamine agonists.

Schapira AH.

Neurology. 2002 Feb 26;58(4 Suppl 1):S9-18. Review.

PMID:
11909981
[PubMed - indexed for MEDLINE]
12.

Dopamine agonists and neuroprotection in Parkinson's disease.

Olanow CW, Jenner P, Brooks D.

Ann Neurol. 1998 Sep;44(3 Suppl 1):S167-74. Review.

PMID:
9749590
[PubMed - indexed for MEDLINE]
13.

Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.

Linazasoro G; Spanish Dopamine Agonists Study Group.

J Neurol. 2004 Mar;251(3):335-9.

PMID:
15015015
[PubMed - indexed for MEDLINE]
14.

[The role of dopaminagonists in the treatment of Parkinson's disease].

Ransmayr G.

Praxis (Bern 1994). 2005 Oct 19;94(42):1633-8. German.

PMID:
16277084
[PubMed - indexed for MEDLINE]
15.

Dopamine agonists and neuroprotection in Parkinson's disease.

Schapira AH.

Eur J Neurol. 2002 Nov;9 Suppl 3:7-14. Review.

PMID:
12464116
[PubMed - indexed for MEDLINE]
16.

Neuroprotection by dopamine agonists.

Lange KW, Rausch WD, Gsell W, Naumann M, Oestreicher E, Riederer P.

J Neural Transm Suppl. 1994;43:183-201. Review.

PMID:
7884400
[PubMed - indexed for MEDLINE]
17.

A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?

Clarke CE.

Mov Disord. 2004 May;19(5):491-8. Review.

PMID:
15133811
[PubMed - indexed for MEDLINE]
18.

The role of dopamine agonists in early Parkinson's disease.

Watts RL.

Neurology. 1997 Jul;49(1 Suppl 1):S34-48. Review.

PMID:
9222273
[PubMed - indexed for MEDLINE]
19.

Slowing Parkinson's disease progression: recent dopamine agonist trials.

Pan T, Le W, Jankovic J.

Neurology. 2004 Jan 27;62(2):343; author reply 343-4. No abstract available.

PMID:
14750218
[PubMed - indexed for MEDLINE]
20.

Pergolide in the treatment of patients with early and advanced Parkinson's disease.

Bonuccelli U, Colzi A, Del Dotto P.

Clin Neuropharmacol. 2002 Jan-Feb;25(1):1-10. Review.

PMID:
11852289
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk